Ozen Filiz, Yegin Zeynep, Saglam Zuhal Aydan, Yavlal Figen, Koc Haydar, Ulasoglu Celal
Istanbul Medeniyet University, Department of Medical Genetics - Istanbul -Turkey.
Sinop University, Medical Laboratory Techniques Program - Sinop - Turkey.
Sleep Sci. 2022 Jan-Mar;15(Spec 1):110-115. doi: 10.5935/1984-0063.20220003.
Excessive daytime sleepiness (EDS) is a common complaint encountered in clinical practice with serious consequences both for individual and society since it can increase the ratio of motor vehicle accidents, work- related incidents, and deaths. Moreover, it also manifests less serious individual consequences. This study aimed to investigate the potential role of PER3-VNTR, 5-HTT-LPR, and 5-HTT-VNTR in terms of constituting liability to EDS. Two hundred eighteen participants (93 complaining about daytime sleepiness and 125 individuals with no serious complaint) were recruited in the study. General daytime of sleepiness was quantified with Epworth sleepiness scale (ESS). DNA extractions were performed from collected blood samples with standart salting-out procedure and genotyped. ESS scores displayed difference between individuals suffering from sleep disturbances and other individuals with values of 12.75±4.55 and 6.34±4.26, respectively. PER3- VNTR and 5-HTT-LPR genotypes did not display association with mean ESS scores. However, 5-HTT-VNTR genotypes showed significant association with mean ESS scores; individuals with 10/10 genotypes had the highest ESS score reflecting this genotype as a liability factor for EDS. We strongly recommend further studies based on circadian/serotonin pathway genes in different populations to reach to a consensus and highlight sleep genetic marker genes which then can be the future targets of pharmacological treatment studies for sleep problems.
日间过度嗜睡(EDS)是临床实践中常见的主诉,对个人和社会都会造成严重后果,因为它会增加机动车事故、工作相关事故及死亡的发生率。此外,它还会导致一些不太严重的个人后果。本研究旨在探讨PER3-VNTR、5-HTT-LPR和5-HTT-VNTR在构成EDS易感性方面的潜在作用。该研究招募了218名参与者(93名主诉日间嗜睡者和125名无严重主诉者)。采用爱泼沃斯嗜睡量表(ESS)对总体日间嗜睡情况进行量化。使用标准盐析法从采集的血样中提取DNA并进行基因分型。ESS评分在睡眠障碍患者和其他个体之间存在差异,分别为12.75±4.55和6.34±4.26。PER3-VNTR和5-HTT-LPR基因型与平均ESS评分无关联。然而,5-HTT-VNTR基因型与平均ESS评分显示出显著关联;10/10基因型个体的ESS评分最高,表明该基因型是EDS的一个易患因素。我们强烈建议在不同人群中基于昼夜节律/血清素途径基因开展进一步研究,以达成共识并突出睡眠遗传标记基因,这些基因随后可能成为睡眠问题药物治疗研究的未来靶点。